Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

NCT03760198 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperhidrosis Primary Focal Axilla

Interventions

DRUG: Meditoxin
OTHER: Placebo

Sponsor

Medy-Tox